Oxford BioDynamics(OXBOF)
$0.000.00 (0.00%)
OXBOF
Oxford BioDynamics financials statements
$0.00
At close:0.00 (0.00%)
Oxford BioDynamics (OXBOF) Ratios
9 Followers
Oxford BioDynamics Ratios
OXBOF's free cash flow for Q2 2026 was £-4.52M. For the 2026 fiscal year, OXBOF's free cash flow was decreased by £-7.00K and operating cash flow was £-4.51M. See a summary of the company’s cash flow.
| Ratios | Sep 25 | Sep 24 | Sep 23 | Sep 22 | Sep 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.88 | 1.97 | 1.79 | 0.95 | 2.91 |
| Quick Ratio | 0.80 | 1.84 | 1.72 | 0.83 | 2.74 |
| Cash Ratio | 0.53 | 0.71 | 1.31 | 0.33 | 0.95 |
| Solvency Ratio | -1.43 | -1.30 | -0.94 | -0.63 | -0.64 |
| Operating Cash Flow Ratio | -2.96 | -3.97 | -2.07 | -1.78 | -2.58 |
| Short-Term Operating Cash Flow Coverage | 0.00 | -9.72 | -10.14 | -7.03 | -9.33 |
| Net Current Asset Value | £ -4.69M | £ -2.70M | £ -2.90M | £ -5.99M | £ -2.00M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.63 | 0.47 | 0.40 | 0.54 | 0.43 |
| Debt-to-Equity Ratio | 4.58 | 1.32 | 1.06 | 2.37 | 0.99 |
| Debt-to-Capital Ratio | 0.82 | 0.57 | 0.52 | 0.70 | 0.50 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 7.25 | 2.78 | 2.66 | 4.38 | 2.30 |
| Debt Service Coverage Ratio | -22.59 | -7.77 | -8.98 | -5.69 | -7.33 |
| Interest Coverage Ratio | -25.27 | -57.31 | -51.77 | -44.11 | -65.89 |
| Debt to Market Cap | 0.00 | 0.13 | 0.01 | 0.06 | 0.02 |
| Interest Debt Per Share | 0.00 | 0.02 | 0.05 | 0.06 | 0.07 |
| Net Debt to EBITDA | -0.38 | -0.38 | -0.12 | -0.84 | -0.69 |
| Profitability Margins | |||||
| Gross Profit Margin | -561.55% | 45.44% | 52.16% | 75.32% | -163.34% |
| EBIT Margin | -1004.57% | -1844.50% | -2195.69% | -4787.01% | -2203.81% |
| EBITDA Margin | -895.07% | -1613.99% | -1929.61% | -3999.35% | -1884.75% |
| Operating Profit Margin | -973.79% | -2027.36% | -2161.96% | -5585.06% | -2202.93% |
| Pretax Profit Margin | -1043.11% | -1879.87% | -2237.45% | -4913.64% | -2237.24% |
| Net Profit Margin | -1018.54% | -1818.71% | -2122.75% | -4357.14% | -1959.53% |
| Continuous Operations Profit Margin | -1018.54% | -1818.71% | -2122.75% | -4357.14% | -1959.53% |
| Net Income Per EBT | 97.64% | 96.75% | 94.87% | 88.67% | 87.59% |
| EBT Per EBIT | 107.12% | 92.73% | 103.49% | 87.98% | 101.56% |
| Return on Assets (ROA) | -137.93% | -95.53% | -67.13% | -59.15% | -43.45% |
| Return on Equity (ROE) | -999.37% | -265.42% | -178.79% | -259.27% | -100.09% |
| Return on Capital Employed (ROCE) | -194.58% | -135.09% | -90.93% | -101.99% | -57.41% |
| Return on Invested Capital (ROIC) | -153.84% | -107.20% | -76.01% | -77.00% | -45.84% |
| Return on Tangible Assets | -159.79% | -107.53% | -76.16% | -68.87% | -46.97% |
| Earnings Yield | -169.28% | -140.47% | -19.84% | -58.52% | -16.31% |
| Efficiency Ratios | |||||
| Receivables Turnover | 1.58 | 0.46 | 0.31 | 0.11 | 0.17 |
| Payables Turnover | 12.22 | 0.36 | 0.50 | 0.04 | 2.35 |
| Inventory Turnover | 37.15 | 1.08 | 0.89 | 0.11 | 2.29 |
| Fixed Asset Turnover | 0.23 | 0.11 | 0.07 | 0.02 | 0.05 |
| Asset Turnover | 0.14 | 0.05 | 0.03 | 0.01 | 0.02 |
| Working Capital Turnover Ratio | 1.01 | 0.23 | 0.34 | 0.07 | 0.04 |
| Cash Conversion Cycle | 211.28 | 130.07 | 860.24 | -1607.82 | 2092.38 |
| Days of Sales Outstanding | 231.33 | 794.85 | 1175.87 | 3386.92 | 2088.31 |
| Days of Inventory Outstanding | 9.83 | 337.65 | 409.88 | 3236.97 | 159.33 |
| Days of Payables Outstanding | 29.88 | 1002.44 | 725.51 | 8231.71 | 155.27 |
| Operating Cycle | 241.16 | 1132.50 | 1585.75 | 6623.89 | 2247.65 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.01 | -0.04 | -0.06 | -0.05 | -0.06 |
| Free Cash Flow Per Share | -0.01 | -0.04 | -0.06 | -0.06 | -0.10 |
| Dividend Paid and CapEx Coverage Ratio | -453.47 | -17.10 | -11.58 | -5.75 | -1.92 |
| Capital Expenditure Coverage Ratio | -453.47 | -17.10 | -11.58 | -5.75 | -1.92 |
| Operating Cash Flow Coverage Ratio | -1.51 | -1.77 | -1.29 | -0.84 | -0.90 |
| Operating Cash Flow to Sales Ratio | -7.04 | -15.99 | -16.26 | -33.62 | -17.35 |
| Free Cash Flow Yield | -117.26% | -130.76% | -16.51% | -53.01% | -21.99% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.59 | -0.71 | -5.04 | -1.71 | -6.13 |
| Price-to-Sales (P/S) Ratio | 6.02 | 12.95 | 107.00 | 74.45 | 120.11 |
| Price-to-Book (P/B) Ratio | 5.90 | 1.89 | 9.01 | 4.43 | 6.14 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.85 | -0.76 | -6.06 | -1.89 | -4.55 |
| Price-to-Operating Cash Flow Ratio | -0.85 | -0.81 | -6.58 | -2.21 | -6.92 |
| Price-to-Earnings Growth (PEG) Ratio | 0.01 | 0.02 | -0.56 | 0.25 | -0.11 |
| Enterprise Value Multiple | -1.05 | -1.18 | -5.67 | -2.70 | -7.06 |
| Enterprise Value | 10.31M | 12.15M | 55.76M | 16.63M | 45.37M |
| EV to EBITDA | -1.05 | -1.18 | -5.67 | -2.70 | -7.06 |
| EV to Sales | 9.41 | 19.10 | 109.33 | 107.97 | 133.05 |
| EV to Free Cash Flow | -1.33 | -1.13 | -6.19 | -2.74 | -5.04 |
| EV to Operating Cash Flow | -1.34 | -1.19 | -6.72 | -3.21 | -7.67 |
| Tangible Book Value Per Share | 0.00 | 0.01 | 0.03 | 0.01 | 0.06 |
| Shareholders’ Equity Per Share | 0.00 | 0.02 | 0.04 | 0.03 | 0.07 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.02 | 0.03 | 0.05 | 0.11 | 0.12 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.01 | -0.05 | -0.07 | -0.07 | -0.07 |
| Tax Burden | 0.98 | 0.97 | 0.95 | 0.89 | 0.88 |
| Interest Burden | 1.04 | 1.02 | 1.02 | 1.03 | 1.02 |
| Research & Development to Revenue | 0.56 | 1.27 | 1.49 | 3.42 | 2.63 |
| SG&A to Revenue | 3.56 | 7.04 | 6.69 | 15.92 | 5.43 |
| Stock-Based Compensation to Revenue | 0.00 | 0.81 | 0.65 | 2.56 | 0.74 |
| Income Quality | 0.69 | 0.85 | 0.77 | 0.68 | 0.78 |
Currency in GBP
